Tomato

For diagnostic purposes, the dosage of Tomato extract is not measured in milligrams but in volume and concentration.

• Percutaneous (Skin Prick) Testing: A single drop of the 1:10 or 1:20 w/v extract is applied to the skin, followed by a prick or puncture through the drop. A positive control (histamine) and negative control (saline) must be used simultaneously.
• Intradermal Testing: If the skin prick test is negative but a high clinical suspicion remains, a healthcare provider may inject 0.02 mL to 0.05 mL of a 1:1000 w/v dilution intradermally to observe for a wheal and flare reaction.

Tomato extract is used in children for allergy diagnosis. The procedure is identical to adult dosing; however, the number of simultaneous tests may be limited to reduce discomfort and the cumulative risk of a systemic reaction. Healthcare providers typically prioritize skin prick testing over intradermal testing in younger children due to the increased sensitivity and risk profile. There is no established safety for Tomato extract in infants under 6 months of age without specialist consultation.

Renal Impairment

No specific dosage adjustments are required for renal impairment when the extract is used for diagnostic skin testing, as systemic absorption is negligible. However, patients with end-stage renal disease may have altered skin reactivity (uremic pruritus), which can interfere with the interpretation of results.

Hepatic Impairment

No adjustments are necessary for diagnostic use. For experimental systemic use of tomato-derived compounds, hepatic clearance should be monitored, as the liver is the primary site for the metabolism of phytoestrogens and carotenoids.

Elderly Patients

Elderly patients may exhibit reduced skin reactivity due to age-related changes in skin turgor and mast cell density. Healthcare providers may need to adjust the interpretation of the wheal size rather than the dose itself.

Tomato extract is not for self-administration. It must be administered by a trained healthcare professional (usually an allergist or immunologist).

1. 1Preparation: The skin (usually the forearm or back) is cleaned with alcohol.
2. 2Application: The extract is applied via a sterile lancet or multi-test device.
3. 3Observation: The patient must remain in the medical office for at least 30 minutes following the test to monitor for signs of anaphylaxis.
4. 4Storage: The extract should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze, as this can denature the allergenic proteins.

Since Tomato extract is used for one-time diagnostic procedures or scheduled immunotherapy, a 'missed dose' usually refers to a missed appointment. If a diagnostic test is missed, it can be rescheduled at any time. If an immunotherapy dose is missed, the healthcare provider will determine if the dose needs to be reduced to prevent a reaction when treatment resumes.

An 'overdose' in the context of Tomato extract involves the administration of too much allergen or an inappropriately high concentration.

• Signs: Massive localized swelling, generalized hives (urticaria), angioedema (swelling of the face or throat), wheezing, and hypotension (low blood pressure).
• Emergency Measures: Immediate administration of epinephrine (0.3 mg for adults) via intramuscular injection, followed by antihistamines, corticosteroids, and emergency transport to a hospital.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to use diagnostic extracts at home. Always inform your doctor of any previous reactions to tomatoes or related plants.

The most frequent side effects of Tomato extract are localized to the site of administration. These include:

• Pruritus (Itching): An intense itching sensation at the test site, typically beginning within minutes and lasting up to an hour.
• Wheal and Flare: A raised, pale bump (wheal) surrounded by a ring of red, inflamed skin (flare). This is the intended diagnostic result but is technically a localized side effect.
• Local Erythema: Redness of the skin that may extend beyond the immediate test site.

• Delayed Local Reaction: Swelling and redness that appears 6 to 24 hours after the test. This is often more painful or itchy than the immediate reaction.
• Small Vesicles: Tiny blisters may form at the site of a particularly strong intradermal reaction.
• Fatigue: Some patients report a feeling of mild lethargy following multiple skin tests.

• Systemic Urticaria: Hives appearing on parts of the body far from the injection site.
• Syncope (Fainting): Often a vasovagal response to the needle or the procedure itself rather than the extract.
• Lymphangitis: Rare inflammation of the lymph vessels draining the test site.

While rare with skin prick testing, serious systemic reactions can occur, especially with intradermal administration.

> Warning: Stop the procedure and call for emergency help immediately if you experience any of the following:

• Anaphylaxis: A life-threatening allergic reaction characterized by a rapid drop in blood pressure and difficulty breathing.
• Angioedema: Significant swelling of the lips, tongue, or throat that may obstruct the airway.
• Bronchospasm: Sudden constriction of the airways causing severe wheezing or chest tightness.
• Hypotension: Feeling lightheaded, dizzy, or fainting due to a sudden decrease in blood pressure.
• Generalized Seizures: Extremely rare, usually associated with severe hypoxia during anaphylaxis.

Because Tomato extract is used intermittently for diagnosis, long-term side effects are uncommon. However, repeated exposure through immunotherapy can lead to:

• Persistent Sensitization: In rare cases, the test itself could theoretically sensitize a previously non-allergic individual, though this is clinically debated.
• Hormonal Fluctuations: Given its classification as an Estrogen Receptor Agonist, theoretical concerns exist regarding long-term systemic exposure and its effect on the endocrine system, though this has not been documented with diagnostic doses.

Most allergenic extracts, including Tomato, carry a class-wide warning regarding the risk of severe systemic reactions.

FDA Warning Summary: This product can cause severe life-threatening systemic reactions, including anaphylaxis. It should only be administered by healthcare providers equipped to manage such emergencies. Patients with unstable asthma or those taking beta-blockers may be at increased risk of severe outcomes and may be less responsive to epinephrine.

Report any unusual symptoms, particularly those occurring after you have left the doctor's office, to your healthcare provider immediately.

Tomato extract is a potent biological agent. Its use is restricted to diagnostic or therapeutic settings under the direct supervision of an allergist. Patients must be screened for existing sensitivities to the Solanaceae family (potatoes, peppers, eggplant) before testing. The most critical safety concern is the potential for a systemic IgE-mediated reaction.

No FDA black box warnings specifically for Tomato are listed as a standalone drug; however, it falls under the general black box warning for all Non-Standardized Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis and should be used with extreme caution in patients with a history of severe asthma or those who are currently taking medications that could complicate the treatment of an allergic reaction.

• Allergic Reactions / Anaphylaxis Risk: The primary risk is a systemic reaction. Patients must be observed for 30 minutes post-administration. Facilities must have an 'anaphylaxis kit' containing epinephrine, oxygen, and IV fluids.
• Asthma Status: Patients with uncontrolled or severe asthma are at a much higher risk for a fatal reaction to allergenic extracts. Testing should be postponed until asthma is well-controlled.
• Skin Conditions: Testing should not be performed on skin areas with active dermatitis, eczema, or psoriasis, as this can lead to false-positive results or increased absorption.
• Cardiovascular Disease: Patients with significant heart disease may not tolerate the physiological stress of a systemic reaction or the effects of the epinephrine required to treat it.

• Pre-test Assessment: Baseline vital signs (blood pressure, heart rate, and sometimes peak flow for asthmatics).
• Post-test Observation: Continuous monitoring for 30 minutes for signs of respiratory distress or skin changes.
• Lab Tests: While not routinely required for the extract itself, patients may undergo serum IgE testing (ImmunoCAP) to correlate with skin test results.

Tomato extract does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery for at least 24 hours. A vasovagal response (fainting) during the procedure also warrants a period of rest before driving.

Alcohol should be avoided for 24 hours before and after allergy testing. Alcohol can increase peripheral vasodilation, which may exacerbate a localized reaction or speed the systemic absorption of the allergen, potentially increasing the risk of a severe reaction.

There is no 'tapering' required for Tomato extract as it is not a daily medication. However, if a patient is undergoing immunotherapy, stopping treatment suddenly will result in a loss of clinical tolerance to tomatoes over time.

> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Tomato testing.

There are no drugs that are strictly 'contraindicated' in the sense of a chemical incompatibility, but certain drugs make the use of Tomato extract dangerously unsafe:

• Beta-Blockers (e.g., Propranolol, Atenolol): These drugs block the effects of epinephrine. If a patient has an anaphylactic reaction to the Tomato extract, epinephrine may be ineffective, leading to a potentially fatal outcome. This is a critical safety interaction.

• ACE Inhibitors (e.g., Lisinopril): These may increase the risk of severe systemic reactions or angioedema during allergy testing.
• Tricyclic Antidepressants (e.g., Amitriptyline): These can potentiate the effect of epinephrine if it is needed to treat a reaction, leading to dangerous spikes in blood pressure.
• MAO Inhibitors (e.g., Phenelzine): Similar to TCAs, these interfere with the breakdown of pressor amines, making the management of a reaction more complex.

• Antihistamines (e.g., Loratadine, Cetirizine, Diphenhydramine): These drugs are the most common cause of false-negative results. They suppress the 'wheal and flare' response. Patients must typically stop oral antihistamines for 3 to 7 days before testing.
• H2 Blockers (e.g., Famotidine): These can also mildly suppress skin reactivity and should be discontinued 48 hours prior to testing.
• Topical Corticosteroids: Application of steroids to the test site will suppress the local immune response and invalidate the test.

• Cross-Reactive Foods: Patients allergic to tomato may also react to other nightshades (potatoes, eggplant). Consuming these foods shortly before a test may increase the baseline level of systemic inflammation.
• Alcohol: As noted, alcohol increases blood flow to the skin and can interfere with the accuracy and safety of the test.

• St. John's Wort: May interact with the cytochrome P450 enzymes responsible for metabolizing the phytoestrogenic components of the extract.
• Lycopene Supplements: High doses of lycopene may theoretically desensitize the estrogen receptor agonism of the extract through competitive binding, though this is not clinically significant for allergy testing.

• Skin Testing: The presence of Tomato extract in the skin will obviously interfere with any other skin tests being performed in the same area.
• Hormonal Panels: Because Tomato contains Estrogen Receptor Agonists, extremely high systemic exposure (not typical of diagnostic use) could theoretically interfere with assays for estradiol or other sex hormones.

For each major interaction, the mechanism usually involves either the suppression of the histamine response (antihistamines) or the interference with the body's emergency response systems (beta-blockers). Management always involves a thorough pre-test medication review.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any 'heart' or 'blood pressure' pills.

Tomato extract must NEVER be used in the following circumstances:

• History of Severe Anaphylaxis to Tomato: If a patient has previously had a life-threatening reaction to eating tomatoes, skin testing is often considered too risky and may be bypassed in favor of blood (in vitro) testing.
• Uncontrolled Asthma: Patients with an FEV1 (Forced Expiratory Volume) of less than 70% of predicted are at an unacceptable risk for fatal bronchospasm during testing.
• Acute Infection: Testing should not be performed during a fever or systemic infection as the immune system is already in a heightened state.

Conditions requiring careful risk-benefit analysis include:

• Pregnancy: While not directly teratogenic, the risk of a systemic reaction (and the resulting hypoxia or the need for epinephrine) poses a risk to the fetus. Testing is usually deferred until postpartum.
• Beta-Blocker Therapy: If the patient cannot safely discontinue beta-blockers, the risk of testing must be weighed against the diagnostic necessity.
• Dermatographism: A condition where the skin wheals easily from any touch. This makes the interpretation of an allergy test impossible as the skin will react to the saline control as well.

Patients should be aware of potential cross-sensitivity with:

• Tobacco: Both are in the Solanaceae family; some proteins may overlap.
• Latex: There is a known 'Latex-Fruit Syndrome' where patients allergic to latex also react to tomatoes due to similar profilin proteins.
• Grass Pollen: Some patients with hay fever react to tomatoes because of cross-reactive proteins like Sola l 4.

> Important: Your healthcare provider will evaluate your complete medical history, including your current lung function and medication list, before prescribing Tomato testing.

Tomato extract is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm. The primary concern during pregnancy is not the extract itself but the potential for a systemic anaphylactic reaction. Anaphylaxis can lead to maternal hypotension and uterine hypoperfusion, resulting in fetal hypoxia. Therefore, diagnostic skin testing with Tomato extract is typically avoided during pregnancy unless the results are essential for immediate management.

It is unknown if the allergenic proteins or the phytoestrogenic components of Tomato extract pass into breast milk. However, given the minute amounts used in diagnostic testing, the risk to a nursing infant is considered negligible. Healthcare providers generally advise that breastfeeding is safe following a skin test, provided the mother did not experience a systemic reaction requiring medication.

Tomato extract is approved for use in children to diagnose food allergies. However, children are more susceptible to rapid-onset systemic reactions. In children under the age of two, the skin may be less reactive, leading to potential false negatives. Pediatricians often use a 'modified' testing panel to limit the number of allergens introduced at one time. Tomato allergy in children is often outgrown, so repeat testing every 1-2 years may be recommended.

In patients over 65, the skin's inflammatory response is often diminished. This can lead to smaller wheal sizes that might be interpreted as negative when an allergy actually exists. Furthermore, geriatric patients are more likely to be on polypharmacy (multiple medications), increasing the risk of drug interactions with beta-blockers or ACE inhibitors. A thorough cardiovascular assessment is necessary before testing.

For diagnostic use, no dose adjustment is required. In the event of systemic exposure, lycopene and other metabolites do not rely heavily on renal clearance for their initial breakdown, though the final metabolites are excreted in the urine. Patients on dialysis may have 'itchy skin' (uremic pruritus) which can make the skin test results difficult to read.

Since the liver processes the phytoestrogenic components (Estrogen Receptor Agonists) of the tomato, patients with severe hepatic impairment (Child-Pugh Class C) might theoretically experience prolonged exposure to these compounds if they were administered systemically. For diagnostic skin testing, no adjustments are needed.

> Important: Special populations require individualized medical assessment to ensure that the benefits of diagnostic testing outweigh the potential risks.

Tomato extract contains a variety of biologically active molecules. The primary immunologic mechanism involves the binding of Sola l proteins to IgE on mast cells. However, its classification as an Estrogen Receptor Agonist [MoA] is due to its content of phytoestrogens like coumestrol and certain isoflavones. These molecules mimic the structure of 17β-estradiol and can bind to both ERα and ERβ. This binding triggers the recruitment of co-activators and the subsequent transcription of estrogen-responsive genes.

Additionally, as an Endoglycosidase [EPC], the extract contains enzymes that can cleave internal glycosidic linkages in polysaccharides. This enzymatic activity is crucial in the plant's physiology but in a pharmacological context, it may influence the stability and processing of the glycoprotein allergens within the extract.

• Onset of Action: For the allergic response, the onset is rapid (5-15 minutes). For estrogenic effects, the onset is delayed as it requires gene transcription (hours to days).
• Duration of Effect: The skin wheal typically resolves within 2-4 hours. The systemic estrogenic modulation, if achieved, can last for the duration of the compound's presence in the plasma.
• Tolerance: Repeated exposure to the allergen can lead to 'desensitization' (immunological tolerance), which is the basis for immunotherapy.

| Parameter | Value |

|---|---|

| Bioavailability | <1% (Percutaneous); ~30% (Oral Lycopene) |

| Protein Binding | >95% (Lycopene/Phytoestrogens to Albumin) |

| Half-life | 2-3 hours (Allergenic proteins); 2-3 days (Lycopene) |

| Tmax | 15-30 minutes (Skin reaction); 6 hours (Oral absorption) |

| Metabolism | Hepatic (CYP450 and Glucuronidation) |

| Excretion | Fecal (Major), Renal (Minor) |

• Molecular Formula: Complex biological mixture (Lycopene: C40H56)
• Molecular Weight: Varies by protein (Sola l 1 is ~14 kDa)
• Solubility: Proteins are water-soluble; Lycopene is highly lipid-soluble.
• Structure: The extract is a non-standardized mixture of proteins, glycoproteins, lipids, and secondary metabolites extracted from the fruit of Solanum lycopersicum.

Tomato is classified as a Non-Standardized Food Allergenic Extract [EPC]. It is related to other nightshade extracts like Potato (Solanum tuberosum) and Bell Pepper (Capsicum annuum). Within the broader therapeutic landscape, it shares properties with other phytoestrogen-containing botanicals like Soy and Red Clover.